On September 25, 2018 Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS), a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin technology platform for cancer, respiratory and other diseases, reported that members of the management team will present at the following upcoming investor conferences in October (Press release, Pieris Pharmaceuticals, SEP 25, 2018, View Source [SID1234529566]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Cantor Fitzgerald Global Healthcare Conference
Tuesday, October 2, 2018 at 11:30AM EDT at the InterContinental New York Barclay Hotel in New York City. A webcast of the Company’s presentation will be available at this link.

Leerink Partners Rare Disease & Oncology Roundtable
Wednesday, October 3, 2018 at 2:00PM EDT at the Lotte New York Palace Hotel in New York City. A webcast of the Company’s presentation will be available at this link.